Purchase Order 75F40123P00079

Award Date 4/6/23
Potential Completion Date 4/5/25
Potential Value $181K
Ultimate Awardee
Bruker Corporation
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Jamaica, NY 11433, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This $2,670,476.00 firm fixed price purchase order was awarded by the Food and Drug Administration (FDA) to Bruker Biospin Corp, a manufacturer of scientific instruments and provider of specialized equipment, maintenance, and support services to U.S. federal government agencies. The contract is for the provision of nuclear magnetic resonance (NMR) spectrometers, upgrades, maintenance, and related support services. It does not have a set-aside designation. Bruker Biospin Corp has previously...
This is a firm fixed-price purchase order awarded by the Department of Health and Human Services Food and Drug Administration to Bruker Biospin Corp, a for-profit manufacturer of scientific instruments, in the amount of $238,161.00. The contract is for the delivery of a cryogenically-cooled 13C direct detect probe and 3 years of preventative maintenance for an existing Bruker nuclear magnetic resonance (NMR) spectrometry system. There was no set-aside designation for this award. The original...
This is a $159,767.50 firm fixed price purchase order contract awarded by the Food and Drug Administration (FDA) to Bruker Biospin Corp, a manufacturer of scientific instruments, for the provision of a Bruker Avance III 500 MHz Nuclear Magnetic Resonance (NMR) system. The contract has no set-aside designation and is for the service and maintenance of this specialized scientific equipment used by the FDA. Bruker Biospin Corp has a history of providing NMR systems, upgrades, and support services...
The Department of Health and Human Services Food and Drug Administration awarded Bruker Biospin Corp. a $21,810 purchase order to provide helium fill maintenance services for a 600 MHz nuclear magnetic resonance spectrometer located in Billerica, Massachusetts. As the prime contractor, Bruker Biospin will perform the requested maintenance through December 2024 on the equipment, which is used to support the FDA's regulatory and research efforts. No subcontractors or set aside designations were...
The Department of Health and Human Services Food and Drug Administration awarded Bruker Biospin Corp a firm fixed price purchase order for $119,796.45 to provide preventive maintenance for an Advance III HD700 nuclear magnetic resonance spectrometer cryoprobe and CryoPlatform system AVHD700X located in Silver Spring, Maryland. The award has a period of performance through February 2025 and includes two optional one-year extension periods. This award responds to a sources sought notification...
The Department of Health and Human Services Food and Drug Administration awarded a $879,190.00 firm fixed price purchase order to Bruker Biospin Corp, a for-profit manufacturer of scientific instruments, to upgrade the agency's 500 and 700 MHz nuclear magnetic resonance (NMR) spectrometers. The contract, which does not have a set-aside designation, will provide new equipment, including a new cryoprobe, backup room temperature probe, and automated sample changers, to improve the sensitivity and...
This is a $93,143.40 fixed-price purchase order contract awarded by the Food and Drug Administration (FDA) to Bruker Biospin Corp, a manufacturer of scientific instruments, for a Bruker Avance III 500 MHz NMR service contract. The contract has a period of performance through September 16, 2021 and is not associated with a larger contract vehicle or set-aside designation. Bruker Biospin Corp is a provider of nuclear magnetic resonance (NMR) spectrometers, maintenance, and support services to...
The Department of Health and Human Services Food and Drug Administration awarded a $120,290.40 firm-fixed-price purchase order to Bruker Biospin Corp, a manufacturer of scientific instruments, for a Cryoprobe/Cryoplatform System Service Agreement. The contract provides for the maintenance and support of specialized cryogenic cooling equipment used in the agency's research and testing programs. This award is not associated with a larger contract vehicle and does not have a set-aside...
This firm-fixed-price purchase order was awarded by the Department of Health and Human Services Food and Drug Administration to Bruker Biospin Corp, a manufacturer of scientific instruments and equipment, for the delivery of a Cryo Probe for Nuclear Magnetic Resonance (NMR) analysis. The contract has a potential value of $187,725.00 and a completion date of December 31, 2020. Bruker Biospin Corp is a subsidiary of Bruker Corporation, which provides specialized equipment, maintenance, and support...
The Department of Health and Human Services Food and Drug Administration awarded Bruker Biospin Corp, a manufacturer of scientific instruments, a $398,050.00 firm-fixed-price purchase order contract to provide an NMR 400 console upgrade and deuterium probe. The contract was not set aside. Bruker Biospin Corp is a subsidiary of Bruker Corporation, which provides specialized equipment, maintenance, and support services to various U.S. federal government agencies. This award supports the FDA's...

This firm fixed-price purchase order was awarded by the Department of Health and Human Services' Food and Drug Administration to Bruker Biospin Corp for maintenance of laboratory equipment. The $180,527.72 contract provides for a two-year agreement covering console, magnet, cryoplatform, and two cryoprobes used for nuclear magnetic resonance spectroscopy. Performance will take place at a laboratory in Jamaica, New York. As the prime and sole contractor, Bruker Biospin Corp will be responsible for maintenance, including scheduled helium refills twice per year, to ensure continued operations of the scientific instruments for the FDA's research and regulatory activities. No subcontractors or set-aside designations were associated with this award to the for-profit manufacturer.

Generated 1/24/24, 9:40 AM